Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Achmea Investment Management B.V. raised its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 9.5% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 445,183 shares of the biopharmaceutical company’s stock after purchasing an additional 38,793 shares during the period. Achmea Investment Management B.V.’s holdings […]
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) had its price target dropped by analysts at Barclays from $62.00 to $60.00 in a report released on Monday, FlyOnTheWall reports. Barclays‘s price objective points to a potential upside of 4.84% from the company’s previous close. Several other analysts have also recently commented on BMY. Daiwa Capital Markets […]
FirstPurpose Wealth LLC raised its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,240 shares of the biopharmaceutical company’s stock after purchasing an additional 184 shares during the quarter. FirstPurpose Wealth LLC’s holdings […]
Ellsworth Advisors LLC raised its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,623 shares of the biopharmaceutical company’s stock after purchasing an additional 482 shares during the quarter. Ellsworth […]